PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1189444
PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1189444
Global radioimmunoassay market is projected to register a substantial CAGR of 4.1% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.
Global Radioimmunoassay Market, By Product Type (Radio Immunoassay Reagents and Kits and Radio Immunoassay Analyser), Application (Scientific Research and Clinical Diagnosis), End User (Hospitals, Clinical Diagnostic Laboratories, Academic and Research Institutes, Pharmaceutical and Biopharmaceutical Industry, Contract Research Organizations, and Other), Distribution Channel (Direct Tender, Online Sales, Third Party Distribution, and Others), Country (U.S., Canada, Mexico, Germany, France, U.K, Italy, Spain, Russia, Turkey, Belgium, Denmark, Netherlands, Switzerland, Sweden, Poland, Norway, Finland, Rest of Europe, China, Japan, India, South Korea, Australia, Indonesia, Philippines, Thailand, Malaysia, Singapore Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, and Rest of Middle East and Africa) Industry Trends and Forecast to 2030.
Increase in the demand for error-free and accurate results of high throughput and automated procedures
Rise in the technological advancements
Strategic initiatives by market players
Increasing significance of research and development in medical science
PerkinElmer Inc.
MP BIOMEDICALS
Tecan Trading AG
Merck KGaA
Immuno-Biological Laboratories Co,Ltd.
EUROIMMUN Medizinische Labordiagnostika AG
KAMIYA BIOMEDICAL COMPANY
Beckman Coulter, Inc.
Demeditec Diagnostics GmbH
MyBioSource.com.
DiaSource
Berthold Technologies GmbH & Co.KG
Hidex Oy.
Institute of Isotopes
Abcam plc